Table 2:

Cannabis and Other Drug Use Screening, SUD Symptom Checklists, Diagnosis & Treatment Pre- & Post-Behavioral Health Integration Implementation (using first visit in each period)

Measure	Pre N=32,295		Post N=39,599		p-value^†
^*Screened for Cannabis Use, n (%)			22457	(56.71)	^*
Report daily use^‡			723	(1.83)	^*
^*SUD Symptom Checklist, n (%)			366	(0.92)	^*
^**New CUD diagnosis, n (%)	17	(0.05)	68	(0.17)	<0.0001
^**New CUD treatment, n (%)
Within 14 days	3	(0.01)	3	(0.01)	0.80
Within 30 days	4	(0.01)	6	(0.02)	0.75
Within 90 days	6	(0.02)	12	(0.03)	0.33
^*Screened for Other Drug Use, n (%)			23185	(58.55)	^*
Report some/any use^‡			364	(0.92)	^*
^*SUD Symptom Checklist, n (%)			136	(0.34)	^*
^**New DUD diagnosis, n (%)	32	(0.10)	51	(0.13)	0.24
^**New DUD treatment, n (%)
Within 14 days	2	(0.01)	12	(0.03)	0.038
Within 30 days	5	(0.02)	15	(0.04)	0.083
Within 90 days	8	(0.02)	22	(0.06)	0.050

^†

P values were calculated using Wald test from fitting Generalized Estimating Equations (GEE) clustered on the patient and using robust variance estimator

Screening & assessments were introduced as part of the pilot implementation.

^‡

Defined as warranting further assessment

^**

New CUD & DUD diagnosis and CUD & DUD treatment are defined in text